Certificate Number

GMPC or Non Compliance

Site Name

Site Address

City

Postcode

Country

Total Records 1281 to 1290 of 1336
Download
GMP Search Results
Certificate Number GMPC or Non-compliance Site Details Country Inspection Date
UK GMP 25076 Insp GMP/IMP 25076/331469-0006 [H] GMPC

MEDPHARM LIMITED, UNIT 1 & UNIT 3 CHANCELLOR COURT, 50 OCCAM ROAD, SURREY RESEARCH PARK, GUILDFORD, GU2 7AB, UNITED KINGDOM

UNITED KINGDOM
UK GMP 25076 Insp GMP/IMP 25076/331469-0006 [V] GMPC

MEDPHARM LIMITED, UNIT 1 & UNIT 3 CHANCELLOR COURT, 50 OCCAM ROAD, SURREY RESEARCH PARK, GUILDFORD, GU2 7AB, UNITED KINGDOM

UNITED KINGDOM
UK API 10082 Insp GMP 10082/1121-0002 GMPC

FUERST DAY LAWSON LIMITED, DEVON HOUSE, 58-60 ST KATHARINE'S WAY, LONDON, E1W 1JP, UNITED KINGDOM

UNITED KINGDOM
UK GMP 30520 Insp GMP 30520/1317065-0001[H] GMPC

BECKMAN COULTER GENOMICS INCORPORATED, 100 PERIMETER PARK DRIVE, MORRISVILLE, 25760-9715, UNITED STATES

UNITED STATES
UK GMP 33497 Insp GMP 33497/514678-0002[H] GMPC

AFTON SCIENTIFIC CORPORATION, 2030 AVON COURT, CHARLOTTESVILLE, 22902, UNITED STATES

UNITED STATES
UK GMP 35564 Insp GMP 35564/1052838-0001[H] GMPC

CENTOCOR ORTHO BIOTECH PRODUCTS LP, 1000 ROUTE 202 SOUTH, RARITAN, 08869, UNITED STATES

UNITED STATES
UK MIA(IMP) 13523 Insp IMP 13523/6549-0013[I] GMPC

QUALITY CONTROL NORTH WEST, STEPPING HILL HOSPITAL, POPLAR GROVE, STOCKPORT, SK2 7JE, UNITED KINGDOM

UNITED KINGDOM
UK GMP 35774 Insp GMP 35774/700608-0002[H] GMPC

AAI PHARMA SERVICES CORPORATION, STABILITY, CLINICAL SUPPLIES, GENERAL WAREHOUSE, 1519 N 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/700612-0002[H] GMPC

AAI PHARMA SERVICES CORPORATION, ANALYTICAL SERVICES, 1717 HALL DRIVE, WILMINGTON, 28405, UNITED STATES

UNITED STATES
UK GMP 35774 Insp GMP 35774/700610-0002[H] GMPC

AAI PHARMA SERVICES CORPORATION, ANALYTICAL, FORMULATIONS DEVELOPMENT, 1206 N 23RD STREET, WILMINGTON, 28405, UNITED STATES

UNITED STATES

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX